Publication: B cells produce less IL-10, IL-6 and TNF-alpha in myasthenia gravis
| dc.contributor.author | DİRESKENELİ, RAFİ HANER | |
| dc.contributor.authors | Yilmaz, Vuslat; Oflazer, Piraye; Aysal, Fikret; Parman, Yesim G.; Direskeneli, Haner; Deymeer, Feza; Saruhan-Direskeneli, Guher | |
| dc.date.accessioned | 2022-03-12T20:26:36Z | |
| dc.date.accessioned | 2026-01-11T06:24:22Z | |
| dc.date.available | 2022-03-12T20:26:36Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | B cells from myasthenia gravis (MG) patients with autoantibodies (Aab) against acetylcholine receptor (AChR), muscle-specific kinase (MuSK) or with no detectable Aab were investigated as cytokine producing cells in this study. B cells were evaluated for memory phenotypes and expressions of IL-10, IL-6 and IL-12A. Induced productions of IL-10, IL-6, IL-12p40, TNF-alpha and LT from isolated B cells in vitro were measured by immunoassays. MG patients receiving immunosuppressive treatment had higher proportions of memory B cells compared with healthy controls and untreated patients. With CD40 stimulation MG patients produced significantly lower levels of IL-10, IL-6. With CD40 and B cell receptor stimulation of B cells, TNF-alpha production also decreased in addition to these cytokines. The lower levels of these cytokine productions were not related to treatment. Our results confirm a disturbance of B cell subpopulations in MG subgroups on immunosuppressive treatment. B cell derived IL-10, IL-6 and TNF-alpha are down-regulated in MG, irrespective of different antibody productions. Ineffective cytokine production by B cells may be a susceptibility factor in dysregulation of autoimmune Aab production. | |
| dc.identifier.doi | 10.3109/08916934.2014.992517 | |
| dc.identifier.eissn | 1607-842X | |
| dc.identifier.issn | 0891-6934 | |
| dc.identifier.pubmed | 25518708 | |
| dc.identifier.uri | https://hdl.handle.net/11424/233492 | |
| dc.identifier.wos | WOS:000354798100003 | |
| dc.language.iso | eng | |
| dc.publisher | TAYLOR & FRANCIS LTD | |
| dc.relation.ispartof | AUTOIMMUNITY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Autoantibody | |
| dc.subject | B cell | |
| dc.subject | cytokine | |
| dc.subject | myasthenia gravis | |
| dc.subject | BLOOD MONONUCLEAR-CELLS | |
| dc.subject | MESSENGER-RNA EXPRESSION | |
| dc.subject | REACTIVE T-CELLS | |
| dc.subject | MULTIPLE-SCLEROSIS | |
| dc.subject | RECEPTOR | |
| dc.subject | CYTOKINES | |
| dc.subject | SUBPOPULATIONS | |
| dc.subject | AUTOIMMUNITY | |
| dc.subject | ACTIVATION | |
| dc.subject | ANTIBODIES | |
| dc.title | B cells produce less IL-10, IL-6 and TNF-alpha in myasthenia gravis | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 207 | |
| oaire.citation.issue | 4 | |
| oaire.citation.startPage | 201 | |
| oaire.citation.title | AUTOIMMUNITY | |
| oaire.citation.volume | 48 |
